It was a tough day for several high-profile stocks as Wall Street analysts took a more cautious stance across multiple sectors. Five companies faced downgrades on Thursday, with shifts in sentiment ranging from logistics giants to biotech firms.
Here's what changed and where these stocks stand now.
The Downgrade Lineup
Canaccord Genuity analyst Edward Nash moved Ventyx Biosciences Inc. (VTYX) from Buy to Hold, trimming the price target from $16 down to $14. The biotech stock closed at $13.73 on Wednesday, trading just below the new target.
BMO Capital analyst Ketan Mamtora downgraded Potlatchdeltic Corp (PCH) from Outperform to Market Perform, slashing the price target from $51 to $45. The forestry and wood products company closed at $40.00 on Wednesday, sitting well below even the reduced target.
Baird analyst David Rodgers took Prologis Inc (PLD) from Outperform to Neutral, though he actually raised the price target slightly from $128 to $130. The logistics real estate giant closed at $126.90 on Wednesday, suggesting limited upside in Rodgers' view despite the higher target.
Piper Sandler analyst Alexander Potter downgraded BorgWarner Inc (BWA) from Overweight to Neutral, cutting the price target from $52 to $51. The automotive components supplier closed at $47.45 on Wednesday, leaving some room to the analyst's new target.
And in what might be the most notable move of the bunch, Wolfe Research analyst Scott Group downgraded United Parcel Service Inc (UPS) from Outperform to Peer Perform, pulling his bullish stance on the shipping giant. United Parcel Service shares closed at $105.41 on Thursday.




